DelMar Pharmaceuticals Inc. | Balance Sheet
Fiscal year is July-June. All values USD Thousands.
2012
2013
2015
2016
2017
2018
Cash & Short Term Investments
1.80
4,136.80
1,754.40
6,157.30
6,586.00
5,972
Total Accounts Receivable
-
11.10
25.80
18.40
76.60
39.50
Other Current Assets
-
170.90
245.00
144.10
1,208.10
1,034.90
Total Current Assets
1.80
4,318.70
2,025.30
6,319.80
7,870.70
7,046.40
Intangible Assets
-
-
-
36.00
40.30
28.40
Other Assets
-
-
550.10
-
-
-
Total Assets
1.80
4,318.70
2,575.40
6,355.80
7,911.00
7,074.90
ST Debt & Current Portion LT Debt
7.50
-
-
-
-
Accounts Payable
2.50
140.50
-
627.40
1,271.30
Other Current Liabilities
0.00
109.00
853.10
-
33.10
Total Current Liabilities
10.00
249.50
853.10
627.40
1,304.40
Long-Term Debt
-
272.40
-
-
-
Other Liabilities
-
4,614.90
2,543.80
869.60
28.10
Total Liabilities
10.00
5,136.70
3,396.90
1,497.00
1,332.50
Common Equity (Total)
8.20
818.00
1,100.00
1,714.00
153.10
Total Shareholders' Equity
8.20
818.00
821.50
4,858.80
6,578.50
Total Equity
8.20
818.00
821.50
4,858.80
6,578.50
Liabilities & Shareholders' Equity
1.80
4,318.70
2,575.40
6,355.80
7,911.00
Preferred Stock (Carrying Value)
-
-
278.50
6,572.80
6,425.40
About DelMar Pharmaceuticals
View Profile
